Ivermectin & Fenbendazole cure cance

BREAKING NEWS: First-in-the-World Ivermectin, Mebendazole and Fenbendazole Protocol in Cancer has been peer-reviewed and published on Sep.19, 2024!

My thanks to lead authors Ilyes Baghli and Pierrick Martinez for their incredible inspired work, FLCCC's Dr.Paul Marik for his extensive work on repurposed drugs and every co-author who worked hard to bring this paper to life.

I hope that this peer-reviewed paper lays the groundwork for a brand new future for Cancer Treatment. 

Many of you know that I have been helping thousands of Cancer patients with high dose Ivermectin, Mebendazole, and Fenbendazole

Grok: Fenbendazole and mebendazole, veterinary and human antiparasitics, have demonstrated anti-cancer effects in lab and animal models by disrupting microtubule formation and metabolism, as supported by reviews like Guzzo et al. (2002) and Chang et al. (2020), though human evidence remains anecdotal or early-stage.

Lead authors Ilyes Baghli and Pierrick Martinez, alongside FLCCC's Paul Marik, emphasize tolerability of the doses for various cancer grades, positioning this as a low-cost repurposed drug approach amid growing interest in metabolic therapies, but experts stress the need for randomized clinical trials to validate efficacy beyond case reports.